Back to RTW INVESTMENTS, LP RTW INVESTMENTS, LP

PTGXPTGX

Showing 8 of 28 quarters

Position history for RTW INVESTMENTS, LPRTW INVESTMENTS, LP's holdings in PROTAGONIST THERAPEUTICS INC

Yes. RTW Investments holds 5,061,175 shares of PTGX (Protagonist Therapeutics), worth $620.4M, as of its Q2 2026 13F filing. It increased the position by 2,122 shares from Q1 2026. RTW Investments has held PTGX since Q3 2019, across 28 quarterly 13F filings. PTGX is 5.3% of RTW Investments' reported 13F portfolio.

Current Value

$620.4M

Current Shares

5.1M

Total Value Change

+$376.2M

Total Shares Change

-364,937

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.1M
+0.0%
$620.4M5.3%$122.58
61
2026-Q1
Unchanged
5.1M
0.0%
$533.2M5.3%$105.40
0
2025-Q4
Decreased
5.1M
-12.1%
$441.9M4.4%$87.34
0
2025-Q3
Unchanged
5.8M
0.0%
$382.4M4.7%$66.43
0
2025-Q2
Increased
5.8M
+0.6%
$318.1M4.5%$55.27
57
2025-Q1
Increased
5.7M
+4.0%
$276.6M4.2%$48.36
59
2024-Q4
Increased
5.5M
+1.3%
$212.2M3.2%$38.60
57
2024-Q3
Increased
5.4M
+2.6%
$244.2M3.5%$45.00
58

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used